Jl. Falany et Cn. Falany, REGULATION OF ESTROGEN ACTIVITY BY SULFATION IN HUMAN MCF-7 BREAST-CANCER CELLS, Oncology research, 9(11-12), 1997, pp. 589-596
Estrogen metabolism is closely associated with the growth, progression
, and treatment of breast cancer because many breast cancers are depen
dent upon estrogens for both growth and progression. Factors that affe
ct the intracellular metabolism of estrogens may be critical in alteri
ng the effects of estrogens on breast cancer cells. MCF-7 cells have b
een used as a model system to study the effects of estrogens on breast
cancer cellular growth. Because normal human mammary epithelial (HME)
cells contain estrogen sulfotransferase (EST), which is involved in t
he inactivation of estrogens via sulfation, and MCF-7 cells do not pos
sess this enzyme, the absence of EST may be critical to the growth of
MCF-7 cells in the presence of estrogens. To study the effects of EST
on cellular growth, MCF-7 cells stably transformed with an EST express
ion vector were compared to control cells transformed with vector only
. Sulfation of 20 nM E-2 occurs more rapidly with MCF-7 cells transfor
med with EST than with the control cells, thereby rendering E-2 physio
logically inactive. Additionally, these EST/MCF-7 cells sulfate 20 nM
17 alpha-ethinylestradiol (EE2) at a rate similar to that for E-2 but
sulfate 20 nM diethylstilbestrol (DES) much more slowly; these results
correlate with the kinetic characteristics of EST for these steroids.
EST/MCF-7 cells require higher concentrations of E-2 to stimulate gro
wth than do control MCF-7 cells, hypothetically because EST is inactiv
ating E-2 via sulfation, rendering it incapable of binding to the estr
ogen receptor (ER). The effects of EE2 are similar to those of E-2 whe
reas DES is effective at lower concentrations because it is not inacti
vated by EST. Neither control nor EST/MCF-7 cells grow well in the com
plete absence of estrogens, as would be expected because MCF-7 cells a
re estrogen dependent. However, in medium that has not been treated to
remove endogenous estrogens, EST/MCF-7 cells grow more slowly than co
ntrol cells, most likely because EST is inactivating the estrogens in
the medium, making them ineffective in stimulating growth. EST/MCF-7 c
ells possess EST at levels similar to HME cells and are less responsiv
e to estrogens than are MCF-7 cells lacking EST. The loss of EST may b
e a factor in oncogenesis, which leads to altered estrogen metabolism
in breast carcinoma cells.